Back Login for AI Analysis

    PASG (STOCKS)

    Passage Bio, Inc. Common Stock

    $4.575000
    -0.015000 (-0.33%)
    Prev close: $4.590000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    William Chou
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $15.05M
    Employees
    60
    P/E (TTM)
    -0.41
    P/B (TTM)
    3.31
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —
    Analyst Recommendations
    2
    Strong Buy
    4
    Buy
    3
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Jun 2026 (Q2)
    		 $-2.44 $-2.70 +0.2596 +9.62%
    Mar 2026 (Q1)
    		 $-2.16 $-2.85 +0.6858 +24.10%
    Dec 2025 (Q4)
    		 $-3.95 $-2.62 -1.3286 -50.68%
    Sep 2025 (Q3)
    		 $-2.44 $-2.86 +0.4160 +14.57%
    Financial Statements
    TTM (Jun 2026)
    Research and Development $17.16M
    Operating Income/Loss -$39.02M
    Income/Loss From Continuing Operations After Tax -$36.11M
    Income/Loss From Continuing Operations Before Tax -$36.11M
    Net Income/Loss -$36.11M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$36.11M
    Net Income/Loss Available To Common Stockholders, Basic -$36.11M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share -$11.33
    Diluted Earnings Per Share -$11.33
    Basic Average Shares 6,388,320
    Diluted Average Shares 6,388,320
    Assets $25.18M
    Current Assets $25.18M
    Noncurrent Assets $0.00
    Liabilities $20.72M
    Current Liabilities $20.72M
    Accounts Payable $902.00K
    Wages $1.37M
    Other Current Liabilities $18.45M
    Noncurrent Liabilities $0.00
    Equity $4.46M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $4.46M
    Liabilities And Equity $25.18M
    Net Cash Flow From Operating Activities -$33.50M
    Net Cash Flow From Operating Activities, Continuing -$33.50M
    Net Cash Flow From Investing Activities $20.00K
    Net Cash Flow From Investing Activities, Continuing $20.00K
    Net Cash Flow From Financing Activities $22.16M
    Net Cash Flow From Financing Activities, Continuing $22.16M
    Net Cash Flow -$11.32M
    Net Cash Flow, Continuing -$11.32M
    Comprehensive Income/Loss -$36.11M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$36.11M
    Other Comprehensive Income/Loss -$36.11M